Publication Cover
Neurological Research
A Journal of Progress in Neurosurgery, Neurology and Neurosciences
Volume 39, 2017 - Issue 5
1,827
Views
9
CrossRef citations to date
0
Altmetric
Original Research Paper

Lack of association between MTHFR A1298C variant and Alzheimer’s disease: evidence from a systematic review and cumulative meta-analysis

, , , , , & show all
Pages 426-434 | Received 12 Aug 2016, Accepted 16 Feb 2017, Published online: 10 Mar 2017

References

  • Alzheimer’s Association. 2012 Alzheimer’s disease facts and figures. Alzheimers Dement. 2012;8:131–168.
  • Mayeux R, Stern Y. Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2:a006239.
  • Alzheimer’s Association. 2014 Alzheimer’s disease facts and figures. Alzheimers Dement. 2014;10:e47–e92.
  • Baumgart M, Snyder HM, Carrillo MC, et al. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective. Alzheimers Dement. 2015;11:718–726.10.1016/j.jalz.2015.05.016
  • Querfurth HW, LaFerla FM. Alzheimer’s disease. N Engl J Med. 2010;362:329–344. 10.1016/j.bbadis.2015.12.023
  • Karran E, Mercken M, De Strooper B. The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov. 2011;10:698–712.
  • Hooper C, Lovestone S, Sainz-Fuertes R. Alzheimer’s disease, diagnosis and the need for biomarkers. Biomark Insights. 2008;3:317–323.
  • Cross DS, Ivacic LC, Stefanski EL, et al. Population based allele frequencies of disease associated polymorphisms in the Personalized Medicine Research Project. BMC Genet. 2010;11:51.10.1186/1756-0500-7-194
  • McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–269.10.1016/j.jalz.2011.03.005
  • Bekris LM, Yu CE, Bird TD, et al. Genetics of Alzheimer disease. J Geriatr Psychiatry Neurol. 2010;23:213–227.10.1177/0891988710383571
  • Alonso Vilatela ME, López-López M, Yescas-Gómez P. Genetics of Alzheimer’s disease. Arch Med Res. 2012;43:622–631.10.1016/j.arcmed.2012.10.017
  • Lambert JC, Amouyel P. Genetic heterogeneity of Alzheimer’s disease: complexity and advances. Psychoneuroendocrinology. 2007;32(Suppl 1):S62–S70.10.1016/j.psyneuen.2007.05.015
  • Gao Y, Tan MS, Wang HF, et al. ZCWPW1 is associated with late-onset Alzheimer’s disease in Han Chinese: a replication study and meta-analyses. Oncotarget. 2016;7:20305–20311.
  • Li Y, Song D, Jiang Y, et al. CR1 rs3818361 polymorphism contributes to Alzheimer’s disease susceptibility in Chinese population. Mol Neurobiol. 2016;53:4054–4059.10.1007/s12035-015-9343-7
  • Wang M, Yang J, Su J. Relationship between the polymorphism in exon 5 of BACE1 gene and Alzheimer’s disease. Aging Clin Exp Res. 2016; [ Epub ahead of print]. DOI:10.1007/s40520-016-0539-0
  • Mansouri L, Fekih-Mrissa N, Klai S, et al. Association of methylenetetrahydrofolate reductase polymorphisms with susceptibility to Alzheimer’s disease. Clin Neurol Neurosurg. 2013;115:1693–1696.
  • Goyette P, Sumner JS, Milos R, et al. Human methylenetetrahydrofolate reductase: isolation of cDNA mapping and mutation identification. Nat Genet. 1994;7:551.
  • Nishiyama M, Kato Y, Hashimoto M, et al. Apolipoprotein E, methylenetetrahydrofolate reductase (MTHFR) mutation and the risk of senile dementia – an epidemiological study using the polymerase chain reaction (PCR) method. J Epidemiol. 2000;10:163–172.
  • Silva VC, Ramos FJ, Freitas EM, et al. Alzheimer’s disease in Brazilian elderly has a relation with homocysteine but not with MTHFR polymorphisms. Arq Neuropsiquiatr. 2006;64:941–945.10.1590/S0004-282X2006000600010
  • Andreassi MG, Botto N, Cocci F, et al. Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease. Hum Genet. 2003;112:171–177.
  • Anello G, Guéant-Rodríguez RM, Bosco P, et al. Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer’s disease. NeuroReport. 2004;15:859–861.10.1097/00001756-200404090-00025
  • Wakutani Y, Kowa H, Kusumi M, et al. Genetic analysis of vascular factors in Alzheimer’s disease. Ann N Y Acad Sci. 2002;977:232–238.10.1111/nyas.2002.977.issue-1
  • Ravaglia G, Forti P, Maioli F, et al. Common polymorphisms in methylenetetrahydrofolate reductase (MTHFR): relationships with plasma homocysteine concentrations and cognitive status in elderly northern italian subjects. Arch Gerontol Geriatr Suppl. 2004;9:339–348.10.1016/j.archger.2004.04.044
  • Bosco P. Association of IL-1 RN*2 allele and methionine synthase 2756 AA genotype with dementia severity of sporadic Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2004;75:1036–1038.10.1136/jnnp.2003.025866
  • Mansoori N, Tripathi M, Luthra K, et al. MTHFR (677 and 1298) and IL-6-174 G/C genes in pathogenesis of Alzheimer’s and vascular dementia and their epistatic interaction. Neurobiol Aging. 2012;33:1003.e1–1003.e8.
  • Giedraitis V, Kilander L, Degerman-Gunnarsson M, et al. Genetic analysis of Alzheimer’s disease in the Uppsala Longitudinal Study of Adult Men. Dement Geriatr Cogn Disord. 2009;27:59–68.10.1159/000191203
  • Linnebank M, Linnebank A, Jeub M, et al. Lack of genetic dispositions to hyperhomocysteinemia in Alzheimer disease. Am J Med Genet A. 2004;131A:101–102.10.1002/ajmg.a.30295
  • Dorszewska J, Florczak J, Rozycka A, et al. Oxidative DNA damage and level of thiols as related to polymorphisms of MTHFR, MTR, MTHFD1 in Alzheimer’s and Parkinson’s diseases. Acta Neurobiol Exp (Wars). 2007;67:113–129.
  • Crow JF. Hardy, Weinberg and language impediments. Genetics. 1999;152:821–825.
  • Ziegler A, Van Steen K, Wellek S. Investigating Hardy–Weinberg equilibrium in case-control or cohort studies or meta-analysis. Breast Cancer Res Tr. 2011;128:197–201.10.1007/s10549-010-1295-z
  • Wells G, Shea B, O’connell D, et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [ Internet]. [ cited 2017 Jan 22]. Available from: www.ohri.ca/programs/clinical_epidemiology/oxford.htm
  • Copas J, Shi JQ. Meta-analysis, funnel plots and sensitivity analysis. Biostatistics (Oxford, England). 2000;1:247–262.10.1093/biostatistics/1.3.247
  • Bagos PG, Nikolopoulos GK. Generalized least squares for assessing trends in cumulative meta-analysis with applications in genetic epidemiology. J Clin Epidemiol. 2009;62:1037–1044.10.1016/j.jclinepi.2008.12.008
  • Muellerleile P, Mullen B. Sufficiency and stability of evidence for public health interventions using cumulative meta-analysis. Am J Public Health. 2006;96:515–522.10.2105/AJPH.2003.036343
  • Peters JL, Sutton AJ, Jones DR, et al. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol. 2008;61:991–996.10.1016/j.jclinepi.2007.11.010
  • Bird TD. Genetic factors in Alzheimer’s disease. N Engl J Med. 2005;352:862–864.10.1016/j.gene.2015.03.014
  • Bertram L, McQueen MB, Mullin K, et al. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet. 2007;39:17–23.10.1038/ng1934
  • Ballard C, Gauthier S, Corbett A, et al. Alzheimer’s disease. Lancet. 2011;377:1019–1031.10.1016/S0140-6736(10)61349-9
  • Chan KY, Wang W, Wu JJ, et al. Epidemiology of Alzheimer’s disease and other forms of dementia in China, 1990–2010: a systematic review and analysis. Lancet. 2013;381:2016–2023.10.1016/S0140-6736(13)60221-4
  • Bredesen DE. Inhalational Alzheimer’s disease: an unrecognized – and treatable – epidemic. Aging. 2016;8:304–313.
  • Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol. 2011;7:137–152.